Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
NT-0796 by NodThera for Atherosclerosis: Likelihood of Approval
NT-0796 is under clinical development by NodThera and currently in Phase II for Atherosclerosis. According to GlobalData, Phase II drugs...
NT-0796 by NodThera for Inflammation: Likelihood of Approval
NT-0796 is under clinical development by NodThera and currently in Phase II for Inflammation. According to GlobalData, Phase II drugs...
NT-0796 by NodThera for Parkinson's Disease: Likelihood of Approval
NT-0796 is under clinical development by NodThera and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase II...